BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32554492)

  • 1. Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
    Lex K; Maia Gil M; Lopes-Bastos B; Figueira M; Marzullo M; Giannetti K; Carvalho T; Ferreira MG
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15066-15074. PubMed ID: 32554492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase is required for zebrafish lifespan.
    Henriques CM; Carneiro MC; Tenente IM; Jacinto A; Ferreira MG
    PLoS Genet; 2013; 9(1):e1003214. PubMed ID: 23349637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of telomere and telomerase during aging and regeneration in zebrafish.
    Anchelin M; Murcia L; Alcaraz-Pérez F; García-Navarro EM; Cayuela ML
    PLoS One; 2011 Feb; 6(2):e16955. PubMed ID: 21347393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of telomerase reduces cancer incidence and increases lifespan of zebrafish tp53
    Şerifoğlu N; Lopes-Bastos B; Ferreira MG
    Sci Rep; 2024 Mar; 14(1):5382. PubMed ID: 38443436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature aging in telomerase-deficient zebrafish.
    Anchelin M; Alcaraz-Pérez F; Martínez CM; Bernabé-García M; Mulero V; Cayuela ML
    Dis Model Mech; 2013 Sep; 6(5):1101-12. PubMed ID: 23744274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short telomeres drive pessimistic judgement bias in zebrafish.
    Espigares F; Abad-Tortosa D; Varela SAM; Ferreira MG; Oliveira RF
    Biol Lett; 2021 Mar; 17(3):20200745. PubMed ID: 33726560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish.
    El Maï M; Marzullo M; de Castro IP; Ferreira MG
    Elife; 2020 May; 9():. PubMed ID: 32427102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-specific telomerase expression counteracts systemic aging in telomerase-deficient zebrafish.
    El Maï M; Bird M; Allouche A; Targen S; Şerifoğlu N; Lopes-Bastos B; Guigonis JM; Kang D; Pourcher T; Yue JX; Ferreira MG
    Nat Aging; 2023 May; 3(5):567-584. PubMed ID: 37142828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of telomeres and telomerase expression in Xiphophorus.
    Downs KP; Shen Y; Pasquali A; Beldorth I; Savage M; Gallier K; Garcia T; Booth RE; Walter RB
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan; 155(1):89-94. PubMed ID: 21619941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomeres in aging and disease: lessons from zebrafish.
    Carneiro MC; de Castro IP; Ferreira MG
    Dis Model Mech; 2016 Jul; 9(7):737-48. PubMed ID: 27482813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
    Celtikci B; Erkmen GK; Dikmen ZG
    Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.
    Serakinci N; Cagsin H; Mavis M
    Methods Mol Biol; 2019; 2045():217-224. PubMed ID: 29542055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length is an epigenetic trait - Implications for the use of telomerase-deficient organisms to model human disease.
    Henriques CM; Ferreira MG
    Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38441152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and characterization of the zebrafish (Danio rerio) telomerase catalytic subunit (telomerase reverse transcriptase, TERT).
    Lau BW; Wong AO; Tsao GS; So KF; Yip HK
    J Mol Neurosci; 2008; 34(1):63-75. PubMed ID: 18157659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tieing together loose ends: telomere instability in cancer and aging.
    Borges G; Criqui M; Harrington L
    Mol Oncol; 2022 Sep; 16(18):3380-3396. PubMed ID: 35920280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics.
    Smith-Sonneborn J
    Curr Aging Sci; 2020; 13(1):11-21. PubMed ID: 31544708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the promoter of the telomerase gene
    Chiba K; Lorbeer FK; Shain AH; McSwiggen DT; Schruf E; Oh A; Ryu J; Darzacq X; Bastian BC; Hockemeyer D
    Science; 2017 Sep; 357(6358):1416-1420. PubMed ID: 28818973
    [No Abstract]   [Full Text] [Related]  

  • 18. Telomere dysfunction in Tert knockout mice delays Braf
    Zhang J; Zhang F; Porter KI; Dakup PP; Wang S; Robertson GP; Gaddameedhi S; Zhu J
    Int J Cancer; 2024 Feb; 154(3):548-560. PubMed ID: 37727982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
    Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
    J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of telomeres and telomerase in cirrhosis and liver cancer.
    Nault JC; Ningarhari M; Rebouissou S; Zucman-Rossi J
    Nat Rev Gastroenterol Hepatol; 2019 Sep; 16(9):544-558. PubMed ID: 31253940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.